42
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Applications of Nanotechnology in Health Care: Perspectives and Opportunities

, , , , , , & show all
Pages B67-B81 | Received 24 Jul 2010, Accepted 09 Oct 2010, Published online: 10 Dec 2010

REFERENCES

  • Feynman , R. P. Plenty of room at the bottom . Available at: http://www.its.caltech.edu/~feynman/plenty.html (accessed June 30, 2008)
  • Taniguchi , N. 1974 . The basic concept of nanotechnology . Presented at the International Congress on Production Engineering, Tokyo, Japan
  • Liu , W. 2006 . Nanoparticles and their biological and environmental applications . J. Biosci. Bioeng. , 102 ( 1 ) : 1 – 7 .
  • Briesen , H. V. , Ramge , P. and Kreuter , J. 2000 . Controlled release of antiretroviral drugs . AIDS Rev. , 2 : 31 – 38 .
  • Brigger , I. , Dubernet , C. and Couvreur , P. 2002 . Nanoparticles in cancer therapy and diagnosis . Adv. Drug Deliv. Rev. , 54 : 631 – 651 .
  • Reis , C. P. , Neufeld , R. J. , Ribeiro , A. J. , Veiga , F. and Nanoencapsulation , I. 2006 . Methods for preparation of drug-loaded polymeric nanoparticles . Nanomedicine: Nanotechnology, Biology, and Medicine , 2 : 8 – 21 .
  • Haley , B. and Frenkel , E. 2008 . Nanoparticles for drug delivery in cancer treatment . Urologic Oncology: Seminars and Original Investigations , 26 ( 1 ) : 57 – 64 .
  • Brower , V. 2006 . Is nanotechnology ready for primetime? . J. Natl. Canc. Inst. , 98 : 9 – 11 .
  • Faunce , T. A. 2007 . Nanotherapeutics: New challenges for safety and cost-effectiveness regulation in Australia . Med. J. Aust. , 186 ( 4 ) : 189 – 191 .
  • Cai , C. , Bakowsky , U. , Rytting , E. , Schaper , A. K. and Kissel , T. 2008 . Charged nanoparticles as protein delivery systems: A feasibility study using lysozyme as model protein . Eur. J. Pharm. Biopharm. , 69 : 31 – 42 .
  • Williams , J. , Lansdown , R. , Sweitzer , R. , Romanowski , M. , LaBell , R. , Ramaswami , R. and Unger , E. 2003 . Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors . J. Contr. Release , 91 : 167 – 172 .
  • Soppimath , K. , Aminabhavi , T. , Kulkarni , A. and Rudzinski , W. 2001 . Biodegradable polymeric nanoparticles as drug delivery devices . J. Contr. Release , 70 : 1 – 20 .
  • Paciotti , G. F. , Myer , L. , Weinreich , D. , Goia , D. , Pavel , N. , McLaughlin , R. E. and Tamarkin , L. 2004 . Colloidal gold: A novel nanoparticle vector for tumor directed drug delivery . Drug Deliv. , 11 : 169 – 183 .
  • Paciotti , G. F. , Kingston , D. G. I. and Tamarkin , L. 2006 . Colloidal gold nanoparticles: A novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors . Drug Dev. Res. , 67 : 47 – 54 .
  • Connor , E. E. , Mwamuka , J. , Gole , A. , Murphy , C. J. and Wyatt , M. D. 2005 . Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity . Small , 1 ( 3 ) : 325 – 327 .
  • Skirtach , A. G. , Javier , A. M. , Kreft , O. , Kohler , K. , Alberola , A. P. , Mohwald , H. , Parak , W. J. and Sukhorukov , G. B. 2006 . Laser-induced release of encapsulated materials inside living cells . Angew. Chem. Int. Ed. , 45 : 4612 – 4617 .
  • Ghosh , P. , Han , G. , De , M. , Kim , C. K. and Rotello , V. M. 2008 . Gold nanoparticles in delivery applications . Adv. Drug Deliv. Rev. , 60 ( 11 ) : 1307 – 1315 .
  • Hong , R. , Han , G. , Fernandez , J. M. , Kim , B. J. , Forbes , N. S. and Rotello , V. M. 2006 . Glutathione mediated delivery and release using monolayer protected nanoparticle carriers . J. Am. Chem. Soc. , 128 : 1078 – 1079 .
  • Sapsford , K. E. , Berti , L. and Medintz , I. L. 2006 . Materials for fluorescence resonance energy transfer analysis: Beyond traditional donor–acceptor combinations . Angew. Chem. Int. Ed. , 45 : 4562 – 4588 .
  • Dulkeith , E. , Morteani , A. C. , Niedereichholz , T. , Klar , T. A. , Feldmann , J. , Levi , S. A. , Van Veggel , F. C. J. M. , Reinhoudt , D. N. , Moller , M. and Gittins , D. I. 2002 . Fluorescence quenching of dye molecules near gold nanoparticles: Radiative and nonradiative effects . Phys. Rev. Lett. , 89 ( 20 ) : 203002
  • Polizzi , M. A. , Stasko , N. A. and Schoenfisch , M. H. 2007 . Water-soluble nitric oxide releasing gold nanoparticles . Langmuir , 23 ( 9 ) : 4938 – 4943 .
  • McIntosh , C. M. , Esposito , E. A. , Boal , A. K. , Simard , J. M. , Martin , C. T. and Rotello , V. M. 2001 . Inhibition of DNA transcription using cationic mixed monolayer protected gold clusters . J. Am. Chem. Soc. , 123 : 7626 – 7629 .
  • Han , G. , Chari , N. S. , Verma , A. , Hong , R. , Martin , C. T. and Rotello , V. M. 2005 . Controlled recovery of the transcription of nanoparticle-bound DNA by intracellular concentrations of glutathione . Bioconjugate Chem. , 16 : 1356 – 1359 .
  • Han , G. , Martin , C. T. and Rotello , V. M. 2006 . Stability of gold nanoparticle-bound DNA toward biological, physical, and chemical agents . Chem. Biol. Drug Des. , 67 : 78 – 82 .
  • Rosi , N. L. , Giljohann , D. A. , Thaxton , C. S. , Lytton-Jean , A. K. R. , Han , M. S. and Mirkin , C. A. 2006 . Oligonucleotide modified gold nanoparticles for intracellular gene regulation . Science , 312 ( 5776 ) : 1027 – 1030 .
  • Bhumkar , D. R. , Joshi , H. M. , Sastry , M. and Pokharkar , V. B. 2007 . Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin . Pharm. Res. , 24 : 1415 – 1526 .
  • Angelatos , A. S. , Radt , B. and Caruso , F. 2005 . Light-responsive polyelectrolyte/gold nanoparticle microcapsules . J. Phys. Chem. , 109 : 3071 – 3076 .
  • Bergen , J. M. , Von Recum , H. A. , Goodman , T. T. , Massey , A. P. and Pun , S. H. 2006 . Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery . Macromol. Biosci. , 6 : 506 – 516 .
  • Fundaro , A. , Cavalli , R. , Bargoni , A. , Vighetto , D. , Zara , G. P. and Gasco , M. R. 2000 . Non stealth and stealth solid lipid nanoparticles(sln) carrying doxorubicin: Pharmacokinetic and tissue distribution after i.v. administration to rats . Pharm. Res. , 42 ( 4 ) : 337 – 343 .
  • Chen , D. , Yang , T. , Liang , W. and Zhang , Q. 2001 . In vitro and in vivo study of two types of long circulating solid lipid nanoparticles containing paclitaxel . Chem. Pharm. Bull. , 49 : 1444 – 1447 .
  • Goppert , T. M. and Müller , R. H. 2005 . Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns . J. Drug Target , 13 ( 3 ) : 179 – 187 .
  • Kaur , I. P. , Bhandari , R. , Bhandari , S. and Kakkar , V. 2008 . Potential of solid lipid nanoparticles in brain targeting . J. Contr. Release , 127 ( 2 ) : 97 – 109 .
  • Begley , C. 1996 . The blood-brain barrier: Principles for targeting peptides and drugs to the central nervous system . J. Pharm. Pharmacol. , 48 : 136 – 146 .
  • Alyautdin , R. , Gothier , D. , Petrov , V. , Kharkevich , D. and Kreuter , J. 1995 . Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles . Eur. J. Pharm. Biopharm. , 41 : 44 – 48 .
  • Kreuter , J. 2001 . Nanoparticulate systems for brain delivery of drugs . Adv. Drug Deliv. Rev. , 47 : 65 – 81 .
  • González-Martín , G. , Figueroa , C. , Merino , I. and Osuna , A. 2000 . Allopurinol encapsulated in polycyanoacrylate nanoparticles as potential lysosomatropic carrier: Preparation and trypanocidal activity . Eur. J. Pharm. Biopharm. , 49 ( 2 ) : 137 – 142 .
  • Harris , J. M. and Chess , R. B. 2003 . Effect of pegylation on pharmaceuticals . Nat. Rev. Drug Discov. , 2 : 214 – 221 .
  • Reddy , L. H. , Sharma , R. K. , Chuttani , K. , Mishra , A. K. and Murthy , R. S. R. 2004 . Etoposide incorporated tripalmitin nanoparticles with different surface charge: Formulation, characterization, radiolabeling, and biodistribution studies . AAPS J. , 6 ( 3 ) : e23
  • Podio , V. , Zara , G. P. , Carazzone , M. , Cavalli , R. and Gasco , M. R. 2000 . Biodistribution of stealth and non-stealth solid lipid nanospheres after intravenous administration to rats . J. Pharm. Pharmacol. , 52 : 1057 – 1063 .
  • McCarthy , J. R. and Weissleder , R. 2008 . Multifunctional magnetic nanoparticles for targeted imaging and therapy . Adv. Drug Deliv. Rev. , 60 ( 11 ) : 1241 – 1251 .
  • Montet , X. , Funovics , M. , Montet-Abou , K. , Weissleder , R. and Josephson , L. 2006 . Multivalent effects of RGD peptides obtained by nanoparticle display . J. Med. Chem. , 49 : 6087 – 6093 .
  • Kelly , K. A. , Setlur , S. R. , Ross , R. , Anbazhagan , R. , Waterman , P. , Rubin , M. A. and Weissleder , R. 2008 . Detection of early prostate cancer using a hepsin-targeted imaging agent . Cancer Res. , 68 : 2286 – 2291 .
  • Muller , R. H. , Jacobs , C. and Kayser , O. 2001 . Nanosuspensions as particulate drug formulations in therapy: Rationale for development and what we can expect for the future . Adv. Drug Deliv. Rev. , 47 : 3 – 19 .
  • Liversidge , G. C. 1996 . “ Drug nanocrystals for improved drug delivery ” . In International Symposium on Controlled Release Bioactive Materials, Workshop on Particulate Drug Delivery Systems Vol. 23 ,
  • Looareesuwan , S. , Chulay , J. D. , Canfield , C. J. and Hutchinson , D. B. 1999 . Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand . Trans. Roy. Soc. Trop. Med. Hyg. , 93 : 637 – 640 .
  • Vauthier , C. , Cabane , B. and Labarre , D. 2008 . How to concentrate nanoparticles and avoid aggregation? . Eur. J. Pharm. Biopharm. , 69 : 466 – 475 .
  • Gaucher , G. , Dufresne , M. H. , Sant , V. P. , Kang , N. , Maysinger , D. and Leroux , J. C. 2005 . Block copolymer micelles: Preparation, characterization and application in drug delivery . J. Contr. Release , 109 : 169 – 188 .
  • Aliabadi , H. M. and Lavasanifar , A. 2006 . Polymeric micelles for drug delivery . Expert Opin. Drug Deliv. , 3 : 139 – 162 .
  • Husseini , G. A. and Pitt , W. G. 2008 . Micelles and nanoparticles for ultrasonic drug and gene delivery . Adv. Drug Deliv. Rev. , 60 ( 10 ) : 1137 – 1152 .
  • Rapoport , N. Y. , Marin , A. P. and Timoshin , A. A. 2000 . Effect of a polymeric surfactant on electron transport in hl-60 cells . Arch. Biochem. Biophys. , 384 : 100 – 108 .
  • Howard , B. , Gao , A. , Lee , S. W. , Seo , M. H. and Rapoport , N. 2006 . Ultrasound-enhanced chemotherapy of drug-resistant breast cancer tumors by micellar-encapsulated paclitaxel . Am. J. Drug Deliv. , 4 : 97 – 104 .
  • Slowing , I. I. , Vivero-Escoto , J. L. , Chia-Wen , W. and Lin , V. Y. 2008 . Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers . Adv. Drug Deliv. Rev. , 60 ( 11 ) : 1278 – 1288 .
  • Radu , D. R. , Lai , C. Y. , Jeftinija , K. , Rowe , E. W. , Jeftinija , S. and Lin , V. S. Y. 2004 . A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent . J. Am. Chem. Soc. , 126 : 13216 – 13217 .
  • Giri , S. , Trewyn , B. G. , Stellmaker , M. P. and Lin , V. S. Y. 2005 . Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles . Angew. Chem. Int. Ed. , 44 : 5038 – 5044 .
  • Vallet-Regi , M. 2006 . Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering . Chem. Eur. J. , 12 ( 23 ) : 5934 – 5943 .
  • Balas , F. , Manzano , M. , Horcajada , P. and Vallet-Regi , M. 2006 . Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials . J. Am. Chem. Soc. , 128 : 8116 – 8117 .
  • Lu , J. , Liong , M. , Zink , J. I. and Tammanoi , F. 2007 . Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs . Small , 3 : 1341 – 46 .
  • Haley , B. and Frenkel , E. 2008 . Nanoparticles for drug delivery in cancer treatment . Urologic Oncology: Seminars and Original Investigations , 26 ( 1 ) : 57 – 64 .
  • Moghimi , S. M. , Hunter , A. C. and Murray , J. C. 2001 . Long-circulating and target-specific nanoparticles: theory to practice . Pharmacol. Rev. , 53 : 283 – 318 .
  • Stolnik , S. , Illum , L. and Davis , S. S. 1995 . Long circulating micropar ticulate drug carriers . Adv. Drug Deliv. Rev. , 16 : 195 – 214 .
  • Nishioka , Y. and Yoshino , H. 2001 . Lymphatic targeting with nanopar ticulate system . Adv. Drug Deliv. Rev. , 47 : 55 – 64 .
  • O’Brien , M. E. , Wigler , N. and Inbar , M. 2004 . Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) vs. conventional doxorubicin for first-line treatment of metastatic breast cancer . Ann. Oncol. , 15 : 440 – 449 .
  • Hofheinz , R. D. , Gnad-Vogt , S. U. and Beyer , U. 2005 . Liposomal encapsulated anti-cancer drugs . Anticancer Drugs , 16 : 691 – 707 .
  • Paal , K. , Muller , J. and Hegedus , L. 2001 . High affinity binding of paclitaxel to human serum albumin . Eur. J. Biochem. , 268 : 2187 – 2191 .
  • Leroux , J. , Cozens , R. and Roesel , J. 1995 . Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice . J. Pharm. Sci. , 84 : 1387 – 1391 .
  • Chorny , M. , Fishbein , I. and Golomb , G. 2000 . Drug delivery systems for the treatment of restenosis . Crit. Rev. Ther. Drug Carrier Syst. , 17 : 249 – 284 .
  • Gershlick , A. H. 2002 . Treating atherosclerosis: Local drug delivery from laboratory studies to clinical trials . Atherosclerosis , 160 ( 2 ) : 259 – 271 .
  • Varshosaz , J. and Soheili , M. 2008 . Production and in vitro characterization of lisinopril-loaded nanoparticles for the treatment of restenosis in stented coronary arteries . J. Microencapsul. , 25 ( 7 ) : 478 – 486 .
  • Boeckle , S. and Wagner , E. 2006 . Optimizing targeted gene delivery: Chemical modification of viral vectors and synthesis of artificial virus vector systems . AAPS J. , 8 ( 4 ) : E731 – E742 .
  • Vasir , J. K. and Labhasetwar , V. 2007 . Biodegradable nanoparticles for cytosolic delivery of therapeutics . Adv. Drug Deliv. Rev. , 59 : 718 – 728 .
  • Santhi , K. , Dhanaraj , S. A. , Koshy , M. , Ponnusankar , S. and Suresh , B. 2000 . Study of biodistribution of methotrexate-loaded bovine serum albumin nanospheres in mice . Drug Dev. Ind. Pharm. , 26 ( 12 ) : 1293 – 1296 .
  • Green , M. R. , Manikhas , G. M. , Orlov , S. , Afanasyev , B. , Makhson , A. M. , Bhar , P. and Hawkins , M. J. 2006 . Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer . Ann. Oncol. , 17 ( 8 ) : 1263 – 1268 .
  • Muro , S. and Muzykantov , V. R. 2005 . Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules . Curr. Pharm. Des. , 11 ( 18 ) : 2383 – 2401 .
  • Kaul , G. and Amiji , M. 2005 . Tumor-targeted gene delivery using poly (ethylene glycol)-modified gelatin nanoparticles: In vitro and in vivo studies . Pharm. Res. , 22 ( 6 ) : 951 – 961 .
  • Azarmi , S. , Roa , W. H. and Löbenberg , R. 2008 . Targeted delivery of nanoparticles for the treatment of lung diseases . Adv. Drug Deliv. Rev. , 60 : 863 – 875 .
  • Pandey , R. , Sharma , A. , Zahoor , A. , Sharma , S. , Khuller , G. K. and Prasad , B. 2003 . Poly (dl-lactide co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis . J. Antimicrob. Chemother. , 52 ( 6 ) : 981 – 986 .
  • Mykhaylyk , O. , Dudchenko , N. and Dudchenko , A. 2005 . Doxorubicin magnetic conjugate targeting upon intravenous injection into mice: High gradient magnetic field inhibits the clearance of nanoparticles from the blood . J. Magn. Magn. Mater. , 293 ( 1 ) : 473 – 482 .
  • Wickline , S. A. and Lanza , G. M. 2003 . Nanotechnology for molecular imaging and targeted therapy . Circulation , 107 ( 8 ) : 1092 – 1095 .
  • Song , J. , Chappell , J. C. , Qi , M. , VanGieson , E. J. , Kaul , S. and Price , R. J. 2002 . Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle . J. Am. Coll. Cardiol. , 39 : 726 – 731 .
  • Rosi , N. L. , Giljohann , D. A. , Thaxton , C. S. , Lytton-Jean , A. K. R. , Han , M. S. and Mirkin , C. A. 2006 . Oligonucleotide modified gold nanoparticles for intracellular gene regulation . Science , 312 : 1027 – 1030 .
  • Bhumkar , D. R. , Joshi , H. M. , Sastry , M. and Pokharkar , V. B. 2007 . Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin . Pharm. Res. , 24 : 1415 – 1526 .
  • Kukowska-Latallo , J. F. , Candido , K. A. , Cao , Z. , Nigavekar , S. S. , Majoros , I. J. , Thomas , T. P. , Balogh , L. P. , Khan , M. K. and Baker , J. R. 2005 . Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer . Cancer Res. , 65 : 5317 – 5324 .
  • Sudimack , J. and Lee , R. J. 2000 . Targeted drug delivery via the folate receptor . Adv. Drug Deliv. Rev. , 41 : 147 – 162 .
  • Hattori , Y. and Maitani , Y. 2005 . Folate-linked lipid-based nanoparticle for targeted gene delivery . Curr. Drug Deliv. , 2 : 243 – 252 .
  • Shvedova , A. A. , Murray , A. R. , Kisin , E. R. , Schwegler-Berry , D. , Kagan , V. E. and Gandelsman , V. Z. 2003 . Exposure to carbon nanotube material: Evidence of exposure-induced oxidant stress in human keratinocyte and bronchial epithelial cells . Free Radic. Res. , 37 : 97
  • Brown , J. S. , Zeman , K. L. and Bennett , W. D. 2002 . Ultrafine particle deposition and clearance in the healthy and obstructed lung . Am. J. Respir. Crit. Care Med. , 166 : 1240 – 47 .
  • Muller , R. H. , Jacobs , C. and Kayser , O. Nanosuspensions as particulate drug for mutations in therapy: rationale for development and what we can expect in the future . Adv. Drug Delivery Rev. , 47 3 – 19 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.